Anika Therapeutics Receives FDA Approvable Letter For Its Cosmetic Tissue Augmentation Product
Wed, 29 Nov 2006 08:00 AM EST
... Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has received an FDA approvable letter for its cosmetic tissue augmentation ("CTA") product. CTA is an injectable soft tissue filler for facial wrinkles, scar remediation and lip augmentation. [click link for full article] ...
Related Topics
- Cosmetics
- Cosmetic
- Connective Tissue
- Plastic and Cosmetic Surgery
- Household Poisons
- Cosmetic Dentistry
- Pharmacology
- Consumer Product Safety
- Soft Tissue Sarcoma
- Connective Tissue Disorders
- Carcinogens
- Breast Augmentation
- Referral
- Rosacea
- Scars
- Dentistry
- Organ Donation
- Tacrolimus ointment
- Food Labeling
- Skin Care

Not Signed In -


